Limbix

Healthcare provider sitting next to a hospital bed with a teenager in it looking at a phone
Big Health acquires prescription PDTx company Limbix
By Jessica Hagen | 04:36 pm | July 14, 2023
The San Francisco-based company will add Limbix's SparkRx offering to its digital therapeutics portfolio.   
A woman wearing a mask looking out a window
Limbix raises $15M for adolescent mental healthcare
By Emily Olsen | 01:37 pm | December 07, 2021
The company’s digital therapeutic aimed at treating depression in teens, SparkRx, was launched in October.
DTx regulatory teams talk the power of research beyond ticking FDA's boxes
By Laura Lovett | 04:16 pm | September 17, 2020
Panelists at DTx East discuss the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold. 
Palo Alto company Limbix grabs $9M to develop a digital therapeutic for teens with depression
By Laura Lovett | 04:32 pm | May 06, 2020
GSR Ventures led the round with participation from sequoia Capital, Storm Ventures, NextGen Venture Partners and BIXINK Therapeutics.